These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 6688641

  • 1. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K, Honda T, Hattori M.
    Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
    [No Abstract] [Full Text] [Related]

  • 2. Deferral of initial therapy for advanced indolent lymphomas.
    Portlock CS.
    Cancer Treat Rep; 1982 Mar; 66(3):417-9. PubMed ID: 7037178
    [No Abstract] [Full Text] [Related]

  • 3. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J.
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract] [Full Text] [Related]

  • 4. Hematologic malignancies: non-Hodgkin's lymphomas.
    DeVita VT.
    Hosp Pract (Off Ed); 1986 Sep 15; 21(9):103-18. PubMed ID: 2427535
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K, Honda T, Hattori M.
    Rinsho Ketsueki; 1984 Feb 15; 25(2):164-8. PubMed ID: 6547984
    [No Abstract] [Full Text] [Related]

  • 7. Role of combined-modality therapy in the curative management of advanced-stage "favorable" non-Hodgkin's lymphomas.
    Kinsella TJ.
    Cancer Treat Rep; 1982 Mar 15; 66(3):421-5. PubMed ID: 7037179
    [No Abstract] [Full Text] [Related]

  • 8. [Malignant lymphoma].
    Shirakawa S, Tanaka I, Kita K.
    Gan No Rinsho; 1985 Jul 15; 31(9 Suppl):1029-35. PubMed ID: 2414479
    [Abstract] [Full Text] [Related]

  • 9. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
    Płuzańska A, Krykowski E, Robak T, Oliskiewicz W, Polkowska E, Dowgier I, Hyjek E.
    Pol Tyg Lek; 1982 Sep 27; 37(36):1049-53. PubMed ID: 6189105
    [No Abstract] [Full Text] [Related]

  • 10. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA, Sarma SK, Ahmed Q.
    Bangladesh Med Res Counc Bull; 1982 Dec 27; 8(2):63-7. PubMed ID: 6897860
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Current status of chemotherapy in the treatment of malignant lymphomas].
    Ohnoshi T, Hayashi K, Ueno K, Tada A, Murashima M, Mizuta J, Tagawa S, Kimura I.
    Gan To Kagaku Ryoho; 1989 May 27; 16(5):1989-96. PubMed ID: 2658838
    [Abstract] [Full Text] [Related]

  • 14. [Maintenance treatment in non-Hodgkin's malignant lymphoma].
    Geib KR, Guran M, Sighetea E.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983 May 27; 35(5):397-402. PubMed ID: 6143357
    [No Abstract] [Full Text] [Related]

  • 15. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Björkholm M, Celsing F, Johansson E, Swedish Lymphoma Study Group.
    Ann Hematol; 2006 Oct 27; 85(10):731-3. PubMed ID: 16838163
    [No Abstract] [Full Text] [Related]

  • 16. "Good risk" non-Hodgkin lymphomas: approaches to management.
    Portlock CS.
    Semin Hematol; 1983 Jan 27; 20(1):25-34. PubMed ID: 6342139
    [No Abstract] [Full Text] [Related]

  • 17. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas.
    Kaku K, Inoue M, Fujii S, Ishida Y, Hiroshige Y, Shinohara K, Nakashima K, Matsumoto N, Kaneko T.
    Nihon Ketsueki Gakkai Zasshi; 1983 Jul 27; 46(4):940-6. PubMed ID: 6195877
    [No Abstract] [Full Text] [Related]

  • 18. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.